Trials / Terminated
TerminatedNCT02154087
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Healthpoint · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assess the influence of HP802-247 on biochemical and cellular markers of inflammation in chronic venous leg ulcers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HP802-247 | 260 µL (130 µL, one spray, of each component) containing 0.5 x 10.6 cells per mL, alternating weekly with Vehicle |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-07-01
- Completion
- 2015-10-01
- First posted
- 2014-06-03
- Last updated
- 2016-10-03
- Results posted
- 2016-10-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02154087. Inclusion in this directory is not an endorsement.